| Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy S Gaikwad, MY Agrawal, I Kaushik, S Ramachandran, SK Srivastava Seminars in cancer biology 86, 137-150, 2022 | 89 | 2022 |
| The evolutionary legacy of immune checkpoint inhibitors I Kaushik, S Ramachandran, C Zabel, S Gaikwad, SK Srivastava Seminars in cancer biology 86, 491-498, 2022 | 53 | 2022 |
| Role of phytochemicals in perturbation of redox homeostasis in cancer S Gaikwad, SK Srivastava Antioxidants 10 (1), 83, 2021 | 34 | 2021 |
| Atovaquone suppresses triple-negative breast tumor growth by reducing immune-suppressive cells N Gupta, S Gaikwad, I Kaushik, SE Wright, MM Markiewski, SK Srivastava International Journal of Molecular Sciences 22 (10), 5150, 2021 | 26 | 2021 |
| Interferon stimulated gene 15 (ISG15) in cancer: An update HM Nguyen, S Gaikwad, M Oladejo, MY Agrawal, SK Srivastava, ... Cancer Letters 556, 216080, 2023 | 7 | 2023 |
| Antioxidant Activity of Phytochemicals in Cancer SR Gaikwad, SK Srivastava Handbook of Oxidative Stress in Cancer: Therapeutic Aspects https://doi.org …, 2022 | 6 | 2022 |
| Targeting ubiquitin-like protein, isg15, as a novel tumor associated antigen in colorectal cancer HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, LM Wood Cancers 15 (4), 1237, 2023 | 5 | 2023 |
| Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics MY Agrawal, S Gaikwad, S Srivastava, SK Srivastava Cancers 14 (22), 5482, 2022 | 4 | 2022 |
| Abstract LB267: Disrupting cytoplasmic proton motive force induces ferroptotic cell death in colorectal cancer: A novel anti-cancer mechanism SR Gaikwad, MA Eltokhy, M Moore, K Kailath, SK Srivastava Cancer Research 84 (7_Supplement), LB267-LB267, 2024 | | 2024 |
| MBO enhances anti-tumor immunity in pancreatic ductal adenocarcinoma by inducing immunogenic apoptosis SR Gaikwad, SK Srivastava Cancer Research 84 (6_Supplement), 5262-5262, 2024 | | 2024 |
| New generation drug development from in-silico identification to preclinical evaluation in glioblastoma M Arunachalam, S Gaikwad, S Ramachandran, SK Srivastava Cancer Research 84 (6_Supplement), 3503-3503, 2024 | | 2024 |
| Targeting the β-catenin signaling axis in osteosarcoma M Curcic, S Gaikwad, SK Srivastava Cancer Research 84 (6_Supplement), 7156-7156, 2024 | | 2024 |
| Vitro bioprinted tumor models and bioinks for solid tumor bioprinting SK Srivastava, S Gaikwad US Patent App. 18/126,214, 2023 | | 2023 |
| Abstract LB201: A novel combination of Listeria-based immunotherapy and repurposed drug combats colorectal cancer SR Gaikwad, HM Nguyen, SK Srivastava, L Wood Cancer Research 83 (8_Supplement), LB201-LB201, 2023 | | 2023 |
| Novel 3D bioprinted pancreatic tumor models for anti-cancer drug assessment SR Gaikwad, SK Srivastava Cancer Research 83 (7_Supplement), 197-197, 2023 | | 2023 |
| A novel drug suppresses pancreatic cancer growth through immunomodulation SR Gaikwad, SK Srivastava Cancer Research 83 (7_Supplement), 580-580, 2023 | | 2023 |
| Targeting Ubiquitin-Like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer. Cancers 2023, 15, 1237 HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, LM Wood | | 2023 |
| Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies SR Gaikwad, SK Srivastava International Journal of Radiation Oncology, Biology, Physics 114 (3), e514-e515, 2022 | | 2022 |
| A Novel Bioprinted Pancreatic Tumor: Goodbye To Flat Biology SR Gaikwad, SK Srivastava TISSUE ENGINEERING PART A 28, 316-317, 2022 | | 2022 |
| Moxidectin unravels the role of Hippo-YAP pathway in maintaining immunity of pediatric glioblastoma I Kaushik, S Gaikwad, SK Srivastava Cancer Research 82 (12_Supplement), 3895-3895, 2022 | | 2022 |
Sanjay Srivastava在 ttuhsc.edu 的电子邮件经过验证
